Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis

被引:16
作者
Fernandez Guerrero, Manuel L. [1 ]
de Gorgolas, Miguel [1 ]
机构
[1] Univ Autonoma Madrid, Dept Internal Med, Div Infect Dis, Fdn Jimenez Diaz, Madrid, Spain
关键词
beta-lactamase-resistant penicillins; glycopeptides; bactericidal activity; staphylococcal bacteraemia;
D O I
10.1093/jac.dkl355
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To compare the activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus and to determine how rapidly their bactericidal activity occurs in cardiac vegetations. Methods: In vitro and in vivo studies using an experimental model of endocarditis in rabbits. Animals were treated for 1, 2 or 3 days with cloxacillin 200 mg/kg intramuscularly three times a day or vancomycin 25 mg/kg intravenously twice a day. Results: Cloxacillin and vancomycin at concentrations 4- and 16-fold the MIC produced a modest decrease in the number of microorganisms at 4 h. After 24 h, cloxacillin produced a decrease in the counts of staphylococci from 2.19 to 4.84 log(10) cfu/mL of inoculum. Only concentrations of vancomycin from 16- to 32-fold the MIC resulted in equivalent decreases. After 24 h of treatment, both antibiotics were equally effective in preventing mortality of rabbits. Cloxacillin produced a greater decrease in the number of staphylococci than vancomycin (3.50 +/- 2.18 log(10) cfu/g vegetation and 6.25 +/- 1.28 log(10) cfu/g vegetation, respectively; P < 0.05) and 41% of rabbits had sterile vegetations in comparison with none with vancomycin (P = 0.035). After 48 and 72 h of treatment, both antimicrobials exhibited equivalent activity. Conclusions: Vancomycin was less rapidly bactericidal than cloxacillin in vivo.
引用
收藏
页码:1066 / 1069
页数:4
相关论文
共 10 条
[1]  
[Anonymous], 2003, Manual of clinical microbiology
[2]   COMPARATIVE EFFICACY OF AMOXICILLIN-CLAVULANATE, CLOXACILLIN, AND VANCOMYCIN AGAINST METHICILLIN-SENSITIVE AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS IN RATS [J].
CANTONI, L ;
WENGER, A ;
GLAUSER, MP ;
BILLE, J .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (05) :989-993
[3]   COMPARATIVE EFFICACY OF DAPTOMYCIN, VANCOMYCIN, AND CLOXACILLIN FOR THE TREATMENT OF STAPHYLOCOCCUS-AUREUS ENDOCARDITIS IN RATS AND ROLE OF TEST CONDITIONS IN THIS DETERMINATION [J].
CANTONI, L ;
GLAUSER, MP ;
BILLE, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) :2348-2353
[4]   TEICOPLANIN VERSUS NAFCILLIN AND VANCOMYCIN IN THE TREATMENT OF EXPERIMENTAL ENDOCARDITIS CAUSED BY METHICILLIN-SUSCEPTIBLE OR METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
CHAMBERS, HF ;
SANDE, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (01) :61-64
[5]   Staphylococcus aureus bacteremia -: Recurrence and the impact of antibiotic treatment in a prospective multicenter study [J].
Chang, FY ;
Peacock, JE ;
Musher, DM ;
Triplett, P ;
MacDonald, BB ;
Mylotte, JM ;
O'Donnell, A ;
Wagener, MM ;
Yu, VL .
MEDICINE, 2003, 82 (05) :333-339
[6]   Rapid decrease of free vancomycin in dense staphylococcal cultures [J].
Ekdahl, C ;
Hanberger, H ;
Hällgren, A ;
Nilsson, M ;
Svensson, E ;
Nilsson, LE .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (09) :596-602
[7]   Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model [J].
LaPlante, KL ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4665-4672
[8]   SLOW RESPONSE TO VANCOMYCIN OR VANCOMYCIN PLUS RIFAMPIN IN METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS [J].
LEVINE, DP ;
FROMM, BS ;
REDDY, BR .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (09) :674-680
[9]   Vancomycin use in a hospital with vancomycin restriction [J].
Roghmann, MC ;
Perdue, BE ;
Polish, L .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (01) :60-63
[10]   VANCOMYCIN FOR STAPHYLOCOCCUS-AUREUS ENDOCARDITIS IN INTRAVENOUS-DRUG-USERS [J].
SMALL, PM ;
CHAMBERS, HF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) :1227-1231